
|Articles|September 22, 2015
- Pharmaceutical Commerce - September/October 2015
Cold Chain 2015 Directory
Advertisement
Articles in this issue
about 10 years ago
Maintaining your digital marketing assetsabout 10 years ago
Cold Chain Global Forum takes shapeabout 10 years ago
Driving Traceability Requirements to True Business Valueabout 10 years ago
Next-Generation Serializationabout 10 years ago
A Conversation with Steve Collis, AmerisourceBergenabout 10 years ago
The quality drive at contract manufacturersabout 10 years ago
The 2015 Biopharma Cold Chain Landscapeabout 10 years ago
Pharma is under-managing its multi-channel marketing effortsabout 10 years ago
Predicting pharma's data-driven futureNewsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Novo Nordisk’s Bloomington Plant Receives FDA OAI Designation Following Contamination and Compliance Issues
2
United States Delays Tariffs on Singapore’s Pharma Exports Amid Ongoing Trade Negotiations
3
Pharma Pulse: Kaiser Permanente Strike Escalates, Takeda Partners with Nabla Bio, and FDA Flags Novo Nordisk Bloomington Site
4
How Healthcare Organizations Can Balance Federal and State AI Regulations
5